Downs Christopher

Track

Insider profile

Performance

Overall performance
2.3
Performance over holding periods
2.3
30 days 90 days 120 days
Average return -14% 8.2% 15.1%
Success rate 9% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Downs Christopher's trades of CNS Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
84.99
Quantity 49,225 -20.1%
Value US$4,686,272
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-02-06 2024-02-01
B Purchase
19,380 -3.4%
416.48
US$4,170,183 		19,380 -3.4% 416.48 US$4,170,183
2023-08-23 2023-08-22
B Purchase
14,621 +30.3%
24.77
US$420,135 		14,621 +30.3% 24.77 US$420,135
2023-04-18 2023-04-17
B Purchase
49,225 -20.1%
84.99
US$4,686,272 		49,225 -20.1% 84.99 US$4,686,272
2021-12-07 2021-12-06
B Purchase
5,000 +3.4%
0.94
US$4,702 		5,000 +3.4% 0.94 US$4,702
2021-11-22 2021-11-19
B Purchase
4,500 +3.2%
1.15
US$5,192 		4,500 +3.2% 1.15 US$5,192
2020-08-25 2020-08-24
B Purchase
142,000 +inf%
2.04
US$289,680 		142,000 +inf% 2.04 US$289,680